Home > News By Company > RNCOS
Budget Incentives to Boost Indian Clinical Trial Market
The incentives offered by the government in union budget on research and development in FY 2011, is anticipated to boost the growth of the Indian clinical trial market, says RNCOS.
(EMAILWIRE.COM, March 25, 2010 ) New Delhi, India - The R&D spending of drug companies could increase to the tune of 25-50% due to the incentives offered by the Indian government in its budget. This will propel the growth of Indian Clinical trial market. According to our new research on the sector titled “Booming Clinical Trials Market in India”, the clinical trial outsourcing market in India is forecast to grow at a CAGR of around 31% during 2010-2012.
The key findings of the report show that the country is poised to become one of the leading destinations for conducting clinical trials, owing to a huge patient pool with both chronic and infectious diseases, high cost savings and easy recruitment of patients. Moreover, the changing regulatory environment and introduction of patent regime has also given a significant boost to the Indian clinical trial market. The report analyzes the regulatory environment of India, which is the most important factor for the development of an industry. It also provides some valuable suggestions, which can be useful for the clients in understanding the long-term prospects of the industry.
The research also reveals that clinical trials in India are mostly conducted in government and private hospitals. On the basis of preliminary enquiries, we have found that there are companies or agencies engaged exclusively in conducting clinical trials in the country.
Although the number ICH/GCP compliant sites in India still remain low in comparison to the western countries, it is expected that the number of clinical trials will rise considerably.
“Booming Clinical Trials Market in India” is an outcome of extensive research and detailed study of the Indian clinical research industry. In this report, all the important performance indicators of the sector have been discussed in detail. The report also features a comprehensive cost analysis of different phases of clinical trials in India in comparison to other developing and developed countries.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
The key findings of the report show that the country is poised to become one of the leading destinations for conducting clinical trials, owing to a huge patient pool with both chronic and infectious diseases, high cost savings and easy recruitment of patients. Moreover, the changing regulatory environment and introduction of patent regime has also given a significant boost to the Indian clinical trial market. The report analyzes the regulatory environment of India, which is the most important factor for the development of an industry. It also provides some valuable suggestions, which can be useful for the clients in understanding the long-term prospects of the industry.
The research also reveals that clinical trials in India are mostly conducted in government and private hospitals. On the basis of preliminary enquiries, we have found that there are companies or agencies engaged exclusively in conducting clinical trials in the country.
Although the number ICH/GCP compliant sites in India still remain low in comparison to the western countries, it is expected that the number of clinical trials will rise considerably.
“Booming Clinical Trials Market in India” is an outcome of extensive research and detailed study of the Indian clinical research industry. In this report, all the important performance indicators of the sector have been discussed in detail. The report also features a comprehensive cost analysis of different phases of clinical trials in India in comparison to other developing and developed countries.
For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM564.htm
Check DISCOUNTED REPORTS on: http://www.rncos.com
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We are a team of industry experts who analyze data collected from credible sources. We provide industry insights and analysis that helps corporations to take timely and accurate business decision in today's globally competitive environment.
Contact Information:
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
RNCOS
Shushmul Maheshwari
Tel: 91-120-4224-700
Email us
This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.
|
Private Equity, Angel Investing
Equity Alliance / Private Equity, Angel Investing, / IPO, Venture Capital & IR services / Equity Alliance International Equityallianceir.com Penny Stocks to Watch Sign up for hot penny stock picks Gains of 500%+ possible! Premiumstockpicks.com/landing/ Your text Ads & PR Text Ads plus unlimited press releases, One release featured/Day for only $575 per month. Read more on Text Ads & PR Your text Ads Here! Text Ads are only $289 per month. Ads are placed same day. More on Text Ads Advertising |




